Stock Screener App

無料 -

インストール

23.81

0.00% 0.00

Iambic Therapeutics, Inc. Common Stock (IAM)

概要ニュース株価時系列ディスカッション予測

Iambic Therapeutics, Inc. Common Stock (IAM) 最新ニュース

Iambic Therapeutics CFO Michael Secora Granted RSUs and Stock Options on October 14, 2026 - Kalkine Media

Form 4 Iambic Therapeutics: Michael Secora (CFO & Chief Corp Dev Ofcr) For: 14 October - Investing.com India

Wilson Sonsini Advises Iambic Therapeutics on $150 Million Initial Public Offering - Wilson Sonsini

Total common shares outstanding of Iambic Therapeutics, Inc. – BOATS:IAM - TradingView

IAM SEC FilingsIambic Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia

Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance

Rachlin Evan Lockwood Reports Initial Indirect Ownership in Iambic Therapeutics via Ascenta Capital - Kalkine Media

Iambic Therapeutics prices IPO at $16 per share to raise $150 million - scanx.trade

Iambic Therapeutics prices IPO at $16 per share - Investing.com

Articles from Iambic Therapeutics, Inc. - FinancialContent

Iambic Announces Pricing of Initial Public Offering - Business Wire

Iambic Therapeutics, Inc. has completed an IPO in the amount of $150 million. - www.marketscreener.com

Iambic Therapeutics Files to List Common Stock on Nasdaq Exchange - Kalkine Media

Diluted net income available to common stockholders of IAMBIC THERAPEUTICS INC – NASDAQ:IAM - TradingView

IAMBIC THERAPEUTICS INC Statistics – NASDAQ:IAM - TradingView

NVIDIA-Backed Iambic Therapeutics Files for IPO - Digital Health News

Iambic Therapeutics, Inc. has filed an IPO in the amount of $100 million. - www.marketscreener.com

DRTS

$12.29

6.61%

DMRA

$18.44

1.60%

BCAX

$16.78

4.77%

SNDX

$12.90

5.49%

NBTX

$21.30

4.18%

OMER

$16.20

13.78%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く